| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e5e04c8b568c851dccaca421d1377ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74955dea096155a76276be97f0ec249d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_658df3b9d24eb5224b37aaf605741db6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-26 |
| filingDate |
2009-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_513b8cb7476374aee78ee712b0d12e72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7466f19618611b35f33ed92e3e17982 |
| publicationDate |
2015-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8969288-B2 |
| titleOfInvention |
Amide based glucagon and superfamily peptide prodrugs |
| abstract |
Prodrug formulations of glucagon superfamily peptides are provided wherein the glucagon superfamily peptide has been modified by the linkage of a dipeptide to the glucagon superfamily through an amide bond linkage. The prodrugs disclosed herein have extended half lives and are converted to the active form at physiological conditions through a non-enzymatic reaction driven by chemical instability. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10758592-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10806797-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021097256-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9932381-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9670261-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9694053-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9745360-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9750788-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9771406-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9751926-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9758561-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9789165-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9775904-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9982029-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018064098-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020160003-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10253079-B2 |
| priorityDate |
2008-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |